FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3040240772> ?p ?o ?g. }

• W3040240772 endingPage "107941" @default.
• W3040240772 startingPage "107941" @default.
• W3040240772 abstract "Distinct antigens have been evaluated with diagnostic purpose for canine and human visceral leishmaniasis (VL), and variable sensitivity and specificity values have been obtained in the assays. In the present study, a Leishmania infantum hypothetical protein called LiHyG, which was identified in an immunoproteomics study in Leishmania infantum amastigote extracts by antibodies in VL dogs sera; was cloned, expressed, purified and evaluated as a recombinant protein (rLiHyG) for the diagnosis of canine and human disease. The recombinant amastigote-specific A2 protein (rA2) and a soluble L. infantum protein extract (SLA) were used as controls. For canine VL, the sensitivity values were of 100%, 57.29% and 48.57%, when rLiHyG, rA2 and SLA were used, respectively, while the specificity values were of 100%, 81.43% and 88.57%, respectively. In addition, AUC values were of 1.00, 0.72 and 0.65, when rLiHyG, rA2 and SLA were used, respectively, while accuracy was of 100%, 72.38% and 75.24%, respectively. For human VL, the sensitivity values were of 100%, 84.00% and 88.00%, when rLiHyG, rA2 and SLA were used, respectively, while the specificity values were of 100%, 58.75% and 73.75%, respectively. In addition, AUC values were of 1.00, 0.76 and 0.83, when rLiHyG, rA2 and SLA were used, respectively, while accuracy was of 100%, 64.8% and 66.6%, respectively. The prognostic role of rLiHyG in the human VL was also evaluated, by means of post-therapeutic serological follow-up with sera samples collected before and six months after treatment. Results showed that treated patients presented significant reductions in the anti-rLiHyG IgG, IgG1, and IgG2 antibody levels, with results being similar to those found in healthy subjects. Testing the rA2 protein and SLA as antigens, lower IgG, IgG1, and IgG2 levels were also found, although they were higher after treatment than those obtained for rLiHyG. In conclusion, results suggested that rLiHyG could be considered for future studies as a diagnostic and/or prognostic marker for canine and human VL." @default.
• W3040240772 created "2020-07-10" @default.
• W3040240772 creator A5002260379 @default.
• W3040240772 creator A5002279455 @default.
• W3040240772 creator A5003708797 @default.
• W3040240772 creator A5008152071 @default.
• W3040240772 creator A5009382879 @default.
• W3040240772 creator A5017457686 @default.
• W3040240772 creator A5028620145 @default.
• W3040240772 creator A5054184461 @default.
• W3040240772 creator A5055151306 @default.
• W3040240772 creator A5057145276 @default.
• W3040240772 creator A5062071191 @default.
• W3040240772 creator A5066479316 @default.
• W3040240772 creator A5067279686 @default.
• W3040240772 creator A5067888096 @default.
• W3040240772 creator A5070084843 @default.
• W3040240772 creator A5072160302 @default.
• W3040240772 creator A5073176841 @default.
• W3040240772 creator A5076724761 @default.
• W3040240772 creator A5087243536 @default.
• W3040240772 creator A5088173866 @default.
• W3040240772 creator A5090719067 @default.
• W3040240772 date "2020-09-01" @default.
• W3040240772 modified "2023-10-17" @default.
• W3040240772 title "A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease" @default.
• W3040240772 cites W1605146840 @default.
• W3040240772 cites W1981620631 @default.
• W3040240772 cites W1982353608 @default.
• W3040240772 cites W1993158258 @default.
• W3040240772 cites W2004181718 @default.
• W3040240772 cites W2045730389 @default.
• W3040240772 cites W2061373991 @default.
• W3040240772 cites W2064231612 @default.
• W3040240772 cites W2069593495 @default.
• W3040240772 cites W2097874743 @default.
• W3040240772 cites W2107915297 @default.
• W3040240772 cites W2113202773 @default.
• W3040240772 cites W2125274566 @default.
• W3040240772 cites W2127322768 @default.
• W3040240772 cites W2131206903 @default.
• W3040240772 cites W2132012768 @default.
• W3040240772 cites W2137286214 @default.
• W3040240772 cites W2147478633 @default.
• W3040240772 cites W2149683006 @default.
• W3040240772 cites W2150776092 @default.
• W3040240772 cites W2154111760 @default.
• W3040240772 cites W2165425843 @default.
• W3040240772 cites W2165599671 @default.
• W3040240772 cites W2171647918 @default.
• W3040240772 cites W2181344304 @default.
• W3040240772 cites W2302469503 @default.
• W3040240772 cites W2518806666 @default.
• W3040240772 cites W2552692877 @default.
• W3040240772 cites W2557508389 @default.
• W3040240772 cites W2765775871 @default.
• W3040240772 cites W2767226767 @default.
• W3040240772 cites W2783841473 @default.
• W3040240772 cites W2789272566 @default.
• W3040240772 cites W2794193139 @default.
• W3040240772 cites W2893303984 @default.
• W3040240772 cites W2904891855 @default.
• W3040240772 cites W2911973985 @default.
• W3040240772 cites W2919646825 @default.
• W3040240772 cites W2946433186 @default.
• W3040240772 cites W2962488319 @default.
• W3040240772 cites W3007550291 @default.
• W3040240772 cites W4293247451 @default.
• W3040240772 doi "https://doi.org/10.1016/j.exppara.2020.107941" @default.
• W3040240772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32622940" @default.
• W3040240772 hasPublicationYear "2020" @default.
• W3040240772 type Work @default.
• W3040240772 sameAs 3040240772 @default.
• W3040240772 citedByCount "4" @default.
• W3040240772 countsByYear W30402407722021 @default.
• W3040240772 countsByYear W30402407722022 @default.
• W3040240772 crossrefType "journal-article" @default.
• W3040240772 hasAuthorship W3040240772A5002260379 @default.
• W3040240772 hasAuthorship W3040240772A5002279455 @default.
• W3040240772 hasAuthorship W3040240772A5003708797 @default.
• W3040240772 hasAuthorship W3040240772A5008152071 @default.
• W3040240772 hasAuthorship W3040240772A5009382879 @default.
• W3040240772 hasAuthorship W3040240772A5017457686 @default.
• W3040240772 hasAuthorship W3040240772A5028620145 @default.
• W3040240772 hasAuthorship W3040240772A5054184461 @default.
• W3040240772 hasAuthorship W3040240772A5055151306 @default.
• W3040240772 hasAuthorship W3040240772A5057145276 @default.
• W3040240772 hasAuthorship W3040240772A5062071191 @default.
• W3040240772 hasAuthorship W3040240772A5066479316 @default.
• W3040240772 hasAuthorship W3040240772A5067279686 @default.
• W3040240772 hasAuthorship W3040240772A5067888096 @default.
• W3040240772 hasAuthorship W3040240772A5070084843 @default.
• W3040240772 hasAuthorship W3040240772A5072160302 @default.
• W3040240772 hasAuthorship W3040240772A5073176841 @default.
• W3040240772 hasAuthorship W3040240772A5076724761 @default.
• W3040240772 hasAuthorship W3040240772A5087243536 @default.
• W3040240772 hasAuthorship W3040240772A5088173866 @default.
• W3040240772 hasAuthorship W3040240772A5090719067 @default.

• next